205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.81%
Revenue growth under 50% of AMD's 17.64%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.64%
Gross profit growth under 50% of AMD's 25.12%. Michael Burry would be concerned about a severe competitive disadvantage.
4.17%
EBIT growth below 50% of AMD's 141.94%. Michael Burry would suspect deeper competitive or cost structure issues.
5.51%
Operating income growth under 50% of AMD's 215.25%. Michael Burry would be concerned about deeper cost or sales issues.
9.20%
Net income growth under 50% of AMD's 242.86%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.14%
EPS growth under 50% of AMD's 266.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
9.56%
Diluted EPS growth under 50% of AMD's 266.67%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.31%
Reduced diluted shares while AMD is at 0.72%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.08%
Dividend growth of 0.08% while AMD is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
10.91%
OCF growth under 50% of AMD's 680.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
21.89%
FCF growth under 50% of AMD's 739.29%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
75.75%
Positive 10Y revenue/share CAGR while AMD is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
22.11%
Positive 5Y CAGR while AMD is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
9.87%
3Y revenue/share CAGR above 1.5x AMD's 2.00%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
220.59%
10Y OCF/share CAGR in line with AMD's 204.25%. Walter Schloss would see both as similarly efficient over the decade.
63.29%
Below 50% of AMD's 907.29%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
50.95%
3Y OCF/share CAGR under 50% of AMD's 497.26%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
255.52%
Net income/share CAGR 1.25-1.5x AMD's 171.62%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
95.58%
Below 50% of AMD's 446.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
57.62%
Below 50% of AMD's 121.88%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
27.78%
Below 50% of AMD's 341.93%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.72%
Negative 5Y equity/share growth while AMD is at 215.15%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.47%
Negative 3Y equity/share growth while AMD is at 318.36%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
601.27%
Dividend/share CAGR of 601.27% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
156.24%
Dividend/share CAGR of 156.24% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.09%
3Y dividend/share CAGR of 102.09% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.43%
Firm’s AR is declining while AMD shows 4.50%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.88%
Inventory is declining while AMD stands at 2.46%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.50%
Asset growth 1.25-1.5x AMD's 2.96%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
6.11%
Under 50% of AMD's 21.74%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.82%
Our R&D shrinks while AMD invests at 8.85%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.